PRESS RELEASES
April 15, 2021
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
March 3, 2021
Ventripoint Diagnostics Receives Additional Wage Subsidy Assistance and
Updates Warrant Exercises
March 2, 2021
Ventripoint JV Begins Training Chinese Cardiologists in Heart Analysis System and Achieves Milestone of First Commercial Sales
April 13, 2021
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious
Use of the VMS Heart Analysis System
March 16, 2021
Ventripoint JV Begins Process to have Heart Analysis System Certified for use in
COVID Patients in China
February 25, 2021
Correction - Ventripoint Diagnostics Issues Shares in Final Payment of
Debenture Interest
February 23, 2021
Ventripoint Heart Analysis System to be used at the Stollery Children’s Hospital to Study Atrial Dysfunction in Children
February 16, 2021
Ventripoint Advances Sales, Marketing, and Distribution Partnership in the
Largest Market in World for Heart Disease: China
February 10, 2021
Ventripoint Diagnostics Issues Shares in Final Payment of Debenture
Interest
February 9, 2021
Ventripoint Diagnostics Upgrades Investor Relations Webpage
November 26, 2020
Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise
February 8, 2021
Ventripoint Issues Option Grants
December 10, 2020
January 4, 2021
Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System
December 15, 2020
Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting
February 5, 2021
Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services
February 3, 2021
Ventripoint Announces Complete Conversion of Secured Convertible Debentures,Exercise of Warrants and Accelerated Expiry Date of Warrants
December 14, 2020
Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today
November 5, 2020
Canada's Largest Cardiac Centre Receives VMS+ 3.0 Ventripoint Whole Heart Analysis System
November 3, 2020
Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment
November 3, 2020
September 30, 2020
Ventripoint Announces Appointment to the Board of Directors and Option Grants
September 25, 2020
Ventripoint Engages Torrey Hill Capital to Provide Investor Relations Services
September 15, 2020
Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading
October 8, 2020
Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center
September 28, 2020
Ventripoint Remotely Installs Whole Heart Analysis in Major European Hospital
Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020
September 23, 2020
September 14, 2020
Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement
September 15, 2020
Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System
October 17, 2019
St. Michael's Hospital to Receive VMS+ 3.0 Whole Heart Analysis System
October 16, 2019
DOWNLOAD PDF